Trade 333

BUY ANET

0.899425528 shares at $171.80 on 2026-05-05

Reasoning

ANET earnings binary event resolved favorably tonight with strong Q1 beat (+7.9% EPS surprise, +4.6% revenue surprise) and raised FY2026 guidance to 25% growth with AI networking target lifted to $3.25B. Rule 27 macro-binary constraint now lifts. Current position is 0.5 shares (~$86, ~1.1% of portfolio). Adding to 3% target is justified given the catalyst thesis #234 was structured around has materialized. Stock at $171.92 remains well below $200 threshold mentioned in playbook reasoning. All corroborating signals present (macro_signal 2560, news_signals 15888 and 16282).

Thesis

ANET is an AI networking infrastructure provider to hyperscalers — directly exposed to the AI-capex narrative and the highest-beta of the three holdings on AI-sector swings. Structural demand driver intact: hyperscalers collectively plan ~$725B of 2026 AI capex, much flowing to networking. The ORCL AI-capex contagion debate names the AI-infra complex and is the central forward risk, but it is sentiment/multiple risk, NOT fundamental demand deterioration; ORCL stock was surging today, easing the contagion narrative. June 15 update: tape flipped from June-12 cyclical-broadening back to decisively TECH-LED risk-on (QQQ +3.08%, tech +3.6%) on the US-Iran peace deal — ANET as the highest-beta AI name should be a prime beneficiary of returning AI-mega-cap leadership. WTI -5% to ~$80 (Strait reopens Friday) unwinds the oil-war premium behind the 4.2% energy-led CPI — disinflationary. Rule 44 has NOT lifted (no sub-3.5% CPI; hike odds >15%) and Rule 41 post-earnings stabilization gate remains binding (lifts only on price holding above pre-earnings $168.76 for 2+ sessions, a named institutional buyer/upgrade, or 38.2% retrace — verify against today's price action before any add). No fundamental deterioration; price well above $125 invalidation. Hold; do NOT add until both Rule 44 and Rule 41 gates clear. June 17 FOMC under Chair Warsh (hawkish dot-plot tail risk) is the next macro gate; NVDA earnings/hyperscaler capex guidance remain key forward catalysts. (long, medium confidence)

Outcome

7-day: -14.40% · 30-day: pending

Cited evidence

News

Macro